NCT04121325

Brief Summary

To conduct a pilot study to evaluate the effects of new GES programming settings on abdominal pain in patients with gastroparesis and existing GES devices, whose abdominal pain has so far been refractory to drugs and/or devices.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 9, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

December 18, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 13, 2020

Completed
Last Updated

October 27, 2023

Status Verified

October 1, 2023

Enrollment Period

3 months

First QC Date

October 4, 2019

Last Update Submit

October 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Abdominal Pain

    Abdominal Pain by Brief Pain Inventory. The values are 0-10, with 10 being worse outcome.

    4 weeks

Study Arms (1)

Gastroparesis patients with abdominal pain

Patients with gastroparesis who have had an Enterra device in place for at least two months who continue to have moderate to severe abdominal pain.

Device: Enterra

Interventions

EnterraDEVICE

To measure validated and subjective pain scores among patients with an existing GES device, and who have a trial of new settings directed at abdominal pain and compare their pain scores to each patient baseline symptoms, done with their previous GES settings.

Gastroparesis patients with abdominal pain

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Gastroparesis patients with abdominal pain.

You may qualify if:

  • Should be able to give informed consent for the study
  • Has Enterra GES device in place for at least 2 months
  • Continue to have moderate to severe abdominal pain on at least one pain questionnaire or \>5 score (on a scale of 0-10 for pain) on the VAS questionnaire for at least 2 months.
  • Abdominal pain should be either persistent; for example, daily for at least \>1 hour, be chronic for \>2 months, and refractory to original Enterra GES settings

You may not qualify if:

  • Unable to provide informed consent
  • Pregnancy
  • Any other active health problems that would render patient unable to complete the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Louisville

Louisville, Kentucky, 40202, United States

Location

MeSH Terms

Conditions

Abdominal Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Study Officials

  • Thomas Abell, MD

    University of Louisville

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 4, 2019

First Posted

October 9, 2019

Study Start

December 18, 2019

Primary Completion

March 13, 2020

Study Completion

March 13, 2020

Last Updated

October 27, 2023

Record last verified: 2023-10

Locations